RESNICK NEUROPSYCHIATRIC HOSPITAL AT — History
CCN 054009 | 3-year financial timeline | COVID resilience: 38/100
🛡️ Public data only — no PHI permitted on this instance.
$66M
Latest Revenue (FY2022)
+3.6%
Revenue CAGR (3yr)
-44.2%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $62M | $65M | $66M | +1.6% | +3.6% |
| Operating Expenses | $82M | $91M | $95M | +4.4% | +8.1% |
| Operating Margin | -32.3% | -40.3% | -44.2% | -9.7% | +0.0% |
| Net Income | $-20M | $-26M | $-29M | -11.4% | +0.0% |
| Licensed Beds | 74 | 74 | 74 | +0.0% | +0.0% |
| Total Patient Days | 23,506 | 24,217 | 24,383 | +0.7% | +1.8% |
| Medicare Day % | 19% | 19% | 17% | -10.9% | -5.5% |
| Medicaid Day % | 11% | 12% | 21% | +85.4% | +42.3% |
COVID Impact & Recovery
Resilience Score: 38/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: +7.2% ($62M → $66M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+3.6%
This Hospital
+7.6%
State Avg
Latest Margin
-44.2%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $68M | -50.1% |
| FY2024 (proj) | $71M | -56.0% |
| FY2025 (proj) | $73M | -62.0% |